...
首页> 外文期刊>Research Journal of Pharmaceutical, Biological and Chemical Sciences >aVEGF-A and its Soluble Receptor Type 1 (sVEGFR-1, sFlt-1) Concentrations in Pregnancies with Intrauterine Growth Restriction in the Presence or Absence of Preeclampsia.
【24h】

aVEGF-A and its Soluble Receptor Type 1 (sVEGFR-1, sFlt-1) Concentrations in Pregnancies with Intrauterine Growth Restriction in the Presence or Absence of Preeclampsia.

机译:子痫前期是否存在子宫内生长受限的妊娠中aVEGF-A及其可溶性1型受体(sVEGFR-1,sFlt-1)的浓度。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

ABSTRACT The aim of this study was to determine the maternal serum aVEGF-A and its soluble receptor type 1 (sVEGFR-1, sFlt-1) concentrations in pregnancies with intrauterine growth restriction (IUGR) in the presence or absence of preeclampsia. The study was performed on 65 normotensive pregnant patients with isolated IUGR, 64 preeclamptic women with IUGR and 51 preeclamptic patients with normal intrauterine foetal growth and 65 healthy normotensive pregnant women with singleton uncomplicated pr.
机译:摘要这项研究的目的是确定在先兆子痫存在或不存在宫内生长受限(IUGR)的孕妇中,母体血清aVEGF-A及其可溶性1型受体(sVEGFR-1,sFlt-1)的浓度。该研究针对65例正常IUGR的正常血压孕妇,64例IUGR的先兆子痫妇女和51例胎儿宫内发育正常的先兆子痫患者以及65例单身无并发症的正常血压的孕妇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号